Collegium Pharmaceutical (COLL) Revenue (2016 - 2025)
Historic Revenue for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to $209.4 million.
- Collegium Pharmaceutical's Revenue rose 3142.48% to $209.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $757.1 million, marking a year-over-year increase of 2633.68%. This contributed to the annual value of $631.4 million for FY2024, which is 1141.24% up from last year.
- Latest data reveals that Collegium Pharmaceutical reported Revenue of $209.4 million as of Q3 2025, which was up 3142.48% from $188.0 million recorded in Q2 2025.
- Collegium Pharmaceutical's Revenue's 5-year high stood at $209.4 million during Q3 2025, with a 5-year trough of $27.4 million in Q4 2021.
- In the last 5 years, Collegium Pharmaceutical's Revenue had a median value of $136.7 million in 2023 and averaged $132.3 million.
- Per our database at Business Quant, Collegium Pharmaceutical's Revenue tumbled by 6412.53% in 2021 and then surged by 37372.27% in 2022.
- Quarter analysis of 5 years shows Collegium Pharmaceutical's Revenue stood at $27.4 million in 2021, then surged by 373.72% to $129.6 million in 2022, then rose by 15.53% to $149.7 million in 2023, then rose by 21.51% to $181.9 million in 2024, then increased by 15.07% to $209.4 million in 2025.
- Its Revenue stands at $209.4 million for Q3 2025, versus $188.0 million for Q2 2025 and $177.8 million for Q1 2025.